FDA Completes Transfer Of Emergency Use Authorization For ReEBOV Ebola Antigen Rapid Test To Zalgen Labs - Laboratory Network

FDA Completes Transfer Of Emergency Use Authorization For ReEBOV Ebola Antigen Rapid Test To Zalgen Labs
Laboratory Network
Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on high-impact, neglected infectious diseases, announced today that its ReEBOV® Antigen Rapid Test received U.S. Food and Drug Administration (FDA) emergency use ...